Tag Archive for: Vasomotor symptoms

The company said the drug eased hot flashes and improved sleep in two late-stage trials, much-needed good news for the German group’s pharmaceuticals unit that is reeling from a recent development setback.

In May 2023, the menopause drug received FDA approval for treating moderate to severe symptoms. Astellas said in Thursday’s announcement that the late-stage results “will support health technology assessment and reimbursement dossiers throughout Europe.”

Veozah, an oral once-daily medication, is the first FDA-approved NK3 receptor antagonist for hot flashes, a common symptom of menopause that can affect health and quality of life.